AstraZeneca PLC Ordinary Shares (AZN) analyst actions
Rating and price-target actions on AZN in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the AZN overview →
1 measured AZN analyst action event.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against AstraZeneca PLC (AZN) And Encourages Shareholders to Reach Out | Press release | +0.23% | -0.13% |
Keep exploring
More AZN: earnings → · SEC filings → · AZN overview →
Other Healthcare names and their analyst actions
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| MYLAN NV ORDINARY SHARES (MYL) | 1,701 | -0.13% | 44% |
| Inspire Medical Systems, Inc. (INSP) | 1,692 | +0.06% | 53% |
| Alexion Pharmaceuticals, Inc (ALXN) | 1,615 | -0.04% | 49% |
| ADMA Biologics Inc (ADMA) | 1,609 | +0.11% | 52% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its analyst actions — that is what the link opens.